• Please learn more about our subsidiaries:

• www.heidelberg-pharma.com
  www.oncogene.com

• Download
• Annual Report 2012
• 3-Month Financial Report 2013

• Meet WILEX:
• ASCO Presentations
• Details on AGM

ENGLISH DEUTSCH

WILEX is a biopharmaceutical company and develops drugs based on antibodies and small molecules with a low side effect profile and targeted treatment of different types of cancer as well as diagnostic agents for specific detection of tumours. WILEX’ aim is to help oncologists administer targeted treatments to carefully diagnosed patients and to enhance patients' quality of life.

Latest News

11.04.2013: WILEX has been selected to give several presentations at ASCO. ... More.

11.04.2013: WILEX publishes 3-months financial report 2013. ... More.